Treatment
Treatment literacy materials that cover the basics of hepatitis C treatment, research on efficacy in different key populations, and global treatment uptake.
Materials in this section
Four Weeks May Be Too Short for Treatment of Recent Hepatitis C
Cutting the duration of Mavyret treatment also cut the likelihood of a cure. More
HCV Treatment at The Liver Meeting: Selected Highlights
The Liver Meeting, organised by the American Association for the Study of Liver Diseases (AASLD), was held as a hybrid event from 4 to 8 November 2022. More
Patient-Centred Models of Hepatitis C Treatment for PWID
Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial. More
HCV Treatment at ILC 2022: Selected Highlights
The International Liver Congress (ILC 2022), convened by the European Association for the Study of the Liver (EASL), was held in London, UK on 22-26 June 2022. More
Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis
Safety and effectiveness using 8 weeks of glecaprevir/pibrentasvir in HCV-infected treatment-naïve patients with compensated cirrhosis: The CREST study More
Efficacy and Safety of Direct-Acting Antiviral Therapies and Baseline Predictors for Treatment Outcomes in Hepatitis C Patients in China
A multicenter, real-world study evaluated the efficacy and safety of direct-acting antiviral regimens among chronic hepatitis C patients in Guangdong, China. More
Inside the Research – a Behind-the-Scenes Look at the Research Highlighted in the 2021 INHSU Prisons Bibliography
INHSU Prisons hosted a virtual event ‘Inside the Research’, which welcomed authors from research papers highlighted in the Annual INHSU Prisons Bibliography 2021. More
DAA Treatment Failures in a Low-Resource Setting with a High Burden of Hepatitis C: a Case Series
A case report discussed a series of 18 HCV patients within a resource-limited setting, who after failing standard regimen also failed to respond to advanced pan-genotypic treatment regimens. More
Characteristics of HCV Resistance in an International Cohort After a Decade of Direct-Acting Antivirals
A study evaluated HCV resistance prevalence and distribution among patients who experienced direct-acting antiviral treatment failure. More
Adoption of New Therapies in the Treatment of Hepatitis: A Verification of the Accuracy of Budget Impact Analysis to Guide Investment Decisions
A study compared the results between theoretical and real-world evidence expenditures for medicines for hepatitis C: boceprevir and telaprevir. More
